Gary A. Lyons, Director: Travere Therapeutics TVTX Sell · Filed 24/10/04

Trade details

Type: Insider sale
Amount: $303,918.65
Shares · price: 21,179 sh · $14.35 a share
Held after: 69,821 sh
Stock: Travere Therapeutics TVTX
Person: Gary A. LyonsDirector
Trade date: 24/10/04
Filed: 24/10/04
Days to filing: 0 days

Sold 23.3% of holdings

Share of holding sold: 23.3%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 24/09/04~24/11/03

Gary A. Lyons's recent trades

Gary A. LyonsDirector
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$317.7K
5,000 sh
$317.7K
Filed 08/18
Traded 08/18
Gary A. LyonsDirector
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$310.7K
5,000 sh
$310.7K
Filed 08/17
Traded 08/17
Gary A. LyonsDirector
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$328.6K
8,000 sh
$328.6K
Filed 04/16
Traded 04/14
Gary A. LyonsOfficer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$245.6K
8,000 sh
$245.6K
Filed 04/14
Traded 04/14
Gary A. LyonsDirector
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$2.3M
15,000 sh
$2.3M
Filed 25/12/04
Traded 25/12/03